Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.450
+0.030 (2.11%)
At close: Oct 29, 2025, 4:00 PM EDT
1.440
-0.010 (-0.69%)
After-hours: Oct 29, 2025, 7:26 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Novel Synthetic Lethality-based Cancer Therapeutics
1.50M
Log In
Novel Synthetic Lethality-based Cancer Therapeutics Growth
157.63%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Sweden
1.50M
Log In
Sweden Growth
157.63%
Log In